MedTrace Logo

Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet

NCT01376193 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2013-05-20

No results posted yet for this study

Summary

The study is designed to investigate the information on safety and efficacy of naratriptan tablets on Japanese subjects with migraine headache during Japanese post-marketing surveillance period.

Conditions

  • Migraine Disorders

Interventions

DRUG

Naratriptan

Collection of safety data

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2011-10-31
Completion
2011-10-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01376193 on ClinicalTrials.gov